Journal Article

Endocarditis Caused by <i>Staphylococcus aureus</i> with Reduced Susceptibility to Vancomycin

Christopher W. Woods, Allen C. Cheng, Vance G. Fowler, Mary Moorefield, Joyce Frederick, George Sakoulas, Venkata G. Meka, Fred C. Tenover, Peter Zwadyk and Kenneth H. Wilson

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 38, issue 8, pages 1188-1191
Published in print April 2004 | ISSN: 1058-4838
Published online April 2004 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/383027
Endocarditis Caused by Staphylococcus aureus with Reduced Susceptibility to Vancomycin

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.

Journal Article.  2411 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.